儿童肥厚型心肌病心脏性猝死新型风险预测模型(HCM Risk-Kids)的建立
该研究基于1024例16岁及以下肥厚型心肌病患者的回顾性多中心纵向队列,开发并内部验证了5年心脏性猝死风险预测模型。模型纳入不明原因晕厥、最大左心室壁厚度、左心房内径、左心室流出道压差和非持续性室性心动过速五个预测变量,5年预测的C统计量为0.69(95%CI 0.66-0.72),校准斜率为0.98(95%CI 0.59-1.38)。
要点
- 儿童肥厚型心肌病SCD年事件率为1.49(95%CI 1.15-1.92)。
- 模型基于五个常规临床变量预测5年SCD风险。
- 5年SCD风险≥6%者每植入10台ICD可能挽救1例。
核心结论
- 该儿童肥厚型心肌病SCD风险分层模型可基于常规临床危险因素提供个体化5年风险估计,但需外部验证确认其在不同人群中的预测准确性。
研究设计与样本
- 模型使用文献预设的预测变量(不明原因晕厥、最大左心室壁厚度、左心房内径、左心室流出道压差、非持续性室性心动过速)开发,并采用bootstrapping进行内部验证。
主要发现
- 1024例患者中699例(68.3%)为男孩,平均年龄11岁(IQR 7-14)。
- 中位随访5.3年(IQR 2.6-8.3;总患者年5984),89例(8.7%)发生猝死或等效事件,年事件率1.49(95%CI 1.15-1.92)。
- 模型预测5年风险的C统计量为0.69(95%CI 0.66-0.72),校准斜率为0.98(95%CI 0.59-1.38)。
- 对于5年SCD风险≥6%的患者,每植入10台ICD,可能潜在挽救1例患者免于5年内SCD。
关键数值与推荐
- 模型预测变量包括不明原因晕厥、最大左心室壁厚度、左心房内径、左心室流出道压差和非持续性室性心动过速。
- 5年SCD风险≥6%可作为ICD植入的潜在获益阈值参考。
临床怎么用
- 临床可利用不明原因晕厥、最大左心室壁厚度、左心房内径、左心室流出道压差和非持续性室性心动过速等常规变量评估儿童HCM患者的5年SCD风险。
- 对于5年SCD风险≥6%的儿童HCM患者,可考虑植入ICD以潜在降低SCD风险。
局限性
- 模型需外部验证研究以证明其在不同患者人群中预测的准确性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Sudden cardiac death (SCD) is the most common mode of death in childhood hypertrophic cardiomyopathy (HCM), but there is no validated algorithm to identify those at highest risk. OBJECTIVE: To develop and validate an SCD risk prediction model that provides individualized risk estimates. DESIGN, SETTING, AND PARTICIPANTS: A prognostic model was developed from a retrospective, multicenter, longitudinal cohort study of 1024 consecutively evaluated patients aged 16 years or younger with HCM. The study was conducted from January 1, 1970, to December 31, 2017. EXPOSURES: The model was developed using preselected predictor variables (unexplained syncope, maximal left-ventricular wall thickness, left atrial diameter, left-ventricular outflow tract gradient, and nonsustained ventricular tachycardia) identified from the literature and internally validated using bootstrapping. MAIN OUTCOMES AND MEASURES: A composite outcome of SCD or an equivalent event (aborted cardiac arrest, appropriate implantable cardioverter defibrillator therapy, or sustained ventricular tachycardia associated with hemodynamic compromise). RESULTS: Of the 1024 patients included in the study, 699 were boys (68.3%); mean (interquartile range [IQR]) age was 11 (7-14) years. Over a median follow-up of 5.3 years (IQR, 2.6-8.3; total patient years, 5984), 89 patients (8.7%) died suddenly or had an equivalent event (annual event rate, 1.49; 95% CI, 1.15-1.92). The pediatric model was developed using preselected variables to predict the risk of SCD. The model's ability to predict risk at 5 years was validated; the C statistic was 0.69 (95% CI, 0.66-0.72), and the calibration slope was 0.98 (95% CI, 0.59-1.38). For every 10 implantable cardioverter defibrillators implanted in patients with 6% or more of a 5-year SCD risk, 1 patient may potentially be saved from SCD at 5 years. CONCLUSIONS AND RELEVANCE: This new, validated risk stratification model for SCD in childhood HCM may provide individualized estimates of risk at 5 years using readily obtained clinical risk factors. External validation studies are required to demonstrate the accuracy of this model's predictions in diverse patient populations.
引用
- Norrish G, Ding T, Field E, et al. Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids). JAMA Cardiol. 2019. PMID: 31411652. doi:10.1001/jamacardio.2019.2861
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。